23 July 2008
Prana Biotechnology announced today that the Company will be hosting a conference call with Geoffrey Kempler, Chairman and CEO, and Dr. Jeffrey Cummings, Chairman of Prana's Research and Development A

17 July 2008
Prana Selected for Hot Topics and Alzheimers Association Press Briefing at ICAD - Dr Jeffrey Cummings to Present Recent Clinical Trial Results

10 July 2008
Neuron to Publish Prana PBT2 preclinical research
- Significant cognitive benefits and reduction in Abeta demonstrates
disease modification benefits
- Full data to be presented at ICAD in C

8 July 2008
Comments on Prana Developments and Future Prospects for Therapeutic Approaches for Alzheimers Disease

21 May 2008
Prana Announces $7 million Placement to Fund Research Programs

13 May 2008
Prana Announces PNAS Publication Describing New Class of Anti-Amyloid Drugs

6 May 2008
Novel Drug Candidates Discovered for Parkinson's Disease Use

18 March 2008
Prana Reports Increase in Percent of Major Shareholder Ownership

14 March 2008
Prana Announces Updated Investor Presentation

14 March 2008
Prana to be Featured in Alzheimer's Disease Conference Call

13 March 2008
Prana Biotechnology to Present at the
Cowen and Company Healthcare Conference

4 March 2008
Prana Responds to Press Comments on Visits by Pharmaceutical Executives

26 February 2008
Prana Announces Success in Phase IIa Clinical Trial of PBT2 in Early Alzheimer's Disease

18 January 2008
Prana today announced that the current online addition of Neurobiology of Aging Journal, has published a paper entitled, Zinc and Copper Modulate Alzheimer A-beta Levels in Human Cerebrospinal Fluid,

2 January 2008
Prana Announces Completion of Phase IIa Trial of PBT2 in Alzheimer's Disease Patients